Furthermore, in RA, not only did the inhibition of Smad7 promote TGFβ/Smad3 signalling and tissue fibrosis, but it also markedly enhanced NF-κB-driven inflammation [146]. The gene discussed is NFKB1; the disease is rheumatoid arthritis.